Henry Schein shifts to higher-margin businesses in dental & medical markets. Upgraded to BUY with 24-30% upside by 2027.
Henry Schein: The Case For An Upgrade From Hold To Buy (NASDAQ:HSIC)

145
Henry Schein shifts to higher-margin businesses in dental & medical markets. Upgraded to BUY with 24-30% upside by 2027.